Although the effects of alternative splicing and post-translational glycosylation of CD44 on its interaction with HA have been widely studied in recent years, few reports have described the effects of alterations in fucosylation on CD44-dependent CAM-DR of ovarian cancer cells. The gene discussed is CD44; the disease is ovarian carcinoma.